Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections
Abstract
During severe infections, Staphylococcus aureus moves from its colonising sites to blood and tissues, and is exposed to new selective pressures, thus potentially driving adaptive evolution. Previous studies have shown the key role of the agr locus in S. aureus pathoadaptation, however a more comprehensive characterisation of genetic signatures of bacterial adaptation may enable prediction of clinical outcomes and reveal new targets for treatment and prevention of these infections. Here, we measured adaptation using within-host evolution analysis of 2,590 S. aureus genomes from 396 independent episodes of infection. By capturing a comprehensive repertoire of single-nucleotide and structural genome variations, we found evidence of a distinctive evolutionary pattern within the infecting populations compared to colonising bacteria. These invasive strains had up to 20-fold enrichments for genome degradation signatures and displayed significantly convergent mutations in a distinctive set of genes, linked to antibiotic response and pathogenesis. In addition to agr-mediated adaptation we identified non-canonical, genome-wide significant loci including sucA-sucB and stp1. The prevalence of adaptive changes increased with infection extent, emphasising the clinical significance of these signatures. These findings provide a high-resolution picture of the molecular changes when S. aureus transitions from colonisation to severe infection and may inform correlation of infection outcomes with adaptation signatures.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting file 1-6.The code to call, filter and annotated within-host variants and to perform the enrichment analysis is available on github at https://github.com/stefanogg/staph_adaptation_paper
-
Large tandem chromosome duplications facilitate niche adaptation during persistent infection with drug-resistant Staphylococcus aureusPublicly available at NCBI BioProject (accession no. PRJEB9193).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI Sequencing Read Archive (SRA) (accession no. SRA027352).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI BioProject (accession no. PRJNA29567).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI BioProject (accession no. PRJNA29569).
-
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease.Publicly available at NCBI BioProject (accession no. PRJEB2862).
-
Within-host evolution of Staphylococcus aureus during asymptomatic carriage.Publicly available at NCBI BioProject (accession no.PRJEB2881).
-
Development of oxacillin resistance in a patient with recurrent Staphylococcus aureus bacteremia.Publicly available at NCBI BioProject (accession no.PRJNA248678).
-
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.Publicly available at NCBI BioProject (accession no.PRJNA259799).
-
Adaptive processes of Staphylococcus aureus isolates during the progression from acute to chronic bone and joint infections in patients.Publicly available at NCBI BioProject (accession no.PRJNA298748).
-
Severe infections emerge from commensal bacteria by adaptive evolution.Publicly available at NCBI BioProject (accession no.PRJEB2862).
-
Emergence and Within-Host Genetic Evolution of Methicillin-Resistant Staphylococcus aureus Resistant to Linezolid in a Cystic Fibrosis Patient.Publicly available at NCBI BioProject (accession no.PRJNA434495).
-
In vivo competition and horizontal gene transfer among distinct Staphylococcus aureus lineages as major drivers for adaptational changes during long-term persistence in humans.Publicly available at NCBI BioProject (accession no.PRJEB22600).
-
Genome Plasticity of agr-Defective Staphylococcus aureus during Clinical Infection.Publicly available at NCBI BioProject (accession no.PRJNA393749).
-
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia.Publicly available at NCBI BioProject (accession no.PRJEB27932).
-
Genomic evolution of Staphylococcus aureus isolates colonizing the nares and progressing to bacteremia.Publicly available at NCBI BioProject (accession no.PRJNA414752).
-
Mutation of Agr Is Associated with the Adaptation of Staphylococcus aureus to the Host during Chronic Osteomyelitis.Publicly available at NCBI BioProject (accession no.PRJNA414566).
-
The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare.Publicly available at NCBI BioProject (accession no.PRJEB20148).
-
Chronic Staphylococcus aureus Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence.Publicly available at NCBI BioProject (accession no.PRJNA446073).
-
Staphylococcus aureus Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection.Publicly available at NCBI BioProject (accession no.PRJNA497214).
-
IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate.Publicly available at NCBI BioProject (accession no.PRJDB8056).
-
Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage.Publicly available at NCBI BioProject (accession no.PRJNA527261).
-
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline.Publicly available at NCBI BioProject (accession no.PRJNA488707).
-
In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.Publicly available at NCBI BioProject (accession no.PRJNA577181).
-
Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.Publicly available at NCBI BioProject (accession no.PRJNA544229).
-
Safety of bacteriophage therapy in severe Staphylococcus aureus infection.Publicly available at NCBI BioProject (accession no.PRJNA541589).
Article and author information
Author details
Funding
National Health and Medical Research Council
- Timothy P Stinear
National Health and Medical Research Council
- Benjamin P Howden
The University of Melbourne
- Stefano G Giulieri
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Bavesh D Kana, University of the Witwatersrand, South Africa
Ethics
Human subjects: Ethics approval was obtained at each partecipating site to the CAMERA2 trial and written informed onsent was obtained from each participant or surrogate decision maker.
Version history
- Received: January 19, 2022
- Preprint posted: February 12, 2022 (view preprint)
- Accepted: June 8, 2022
- Accepted Manuscript published: June 14, 2022 (version 1)
- Version of Record published: July 8, 2022 (version 2)
Copyright
© 2022, Giulieri et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,225
- Page views
-
- 508
- Downloads
-
- 12
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Immunology and Inflammation
Periodontitis drives irreversible destruction of periodontal tissue and is prone to exacerbating inflammatory disorders. Systemic immunomodulatory management continues to be an attractive approach in periodontal care, particularly within the context of ‘predictive, preventive, and personalized’ periodontics. The present study incorporated genetic proxies identified through genome-wide association studies for circulating immune cells and periodontitis into a comprehensive Mendelian randomization (MR) framework. Univariable MR, multivariable MR, subgroup analysis, reverse MR, and Bayesian model averaging (MR-BMA) were utilized to investigate the causal relationships. Furthermore, transcriptome-wide association study and colocalization analysis were deployed to pinpoint the underlying genes. Consequently, the MR study indicated a causal association between circulating neutrophils, natural killer T cells, plasmacytoid dendritic cells, and an elevated risk of periodontitis. MR-BMA analysis revealed that neutrophils were the primary contributors to periodontitis. The high-confidence genes S100A9 and S100A12, located on 1q21.3, could potentially serve as immunomodulatory targets for neutrophil-mediated periodontitis. These findings hold promise for early diagnosis, risk assessment, targeted prevention, and personalized treatment of periodontitis. Considering the marginal association observed in our study, further research is required to comprehend the biological underpinnings and ascertain the clinical relevance thoroughly.
-
- Genetics and Genomics
Recombinant adeno-associated viruses (rAAVs) are the predominant gene therapy vector. Several rAAV vectored therapies have achieved regulatory approval, but production of sufficient rAAV quantities remains difficult. The AAV Rep proteins, which are essential for genome replication and packaging, represent a promising engineering target for improvement of rAAV production but remain underexplored. To gain a comprehensive understanding of the Rep proteins and their mutational landscape, we assayed the effects of all 39,297 possible single-codon mutations to the AAV2 rep gene on AAV2 production. Most beneficial variants are not observed in nature, indicating that improved production may require synthetic mutations. Additionally, the effects of AAV2 rep mutations were largely consistent across capsid serotypes, suggesting that production benefits are capsid independent. Our results provide a detailed sequence-to-function map that enhances our understanding of Rep protein function and lays the groundwork for Rep engineering and enhancement of large-scale gene therapy production.